Sumitomo Pharma Co Ltd
OTC:SMDPY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sumitomo Pharma Co Ltd
OTC:SMDPY
|
JP |
|
I
|
Immuron Ltd
XMUN:ANW
|
AU |
|
DBS Group Holdings Ltd
F:DEVL
|
SG |
|
Pulsar Helium Inc
F:Y3K
|
CA |
|
H
|
HAL Trust
OTC:HALFF
|
NL |
|
M
|
MR. D.I.Y. Holding (Thailand) PCL
SET:MRDIYT
|
TH |
|
D
|
Devon Energy Corp
XMUN:DY6
|
US |
|
AWL Agri Business Ltd
NSE:AWL
|
IN |
Intrinsic Value
Is SMDPY undervalued or overvalued?
See the intrinsic value estimate for 
Sumitomo Pharma Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
SMDPY looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with SMDPY’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Sumitomo Pharma Does
Sumitomo Pharma is a Japanese drug company that develops, makes, and sells prescription medicines. Its business centers on medicines for patients with conditions such as mental health disorders, cancer, diabetes, Parkinson’s disease, and urology-related illnesses. It also works on drug discovery and clinical development, which means it spends money to find new medicines, test them, and bring them to market.
- Headquarters
- Japan JP
- Employees
- 3 832
- IPO date
- May 16, 1949
Latest Earnings Call
- EPS
- ¥39.02
- Expected
- ¥19.13
- Surprise
- +104.0%
- Stock, day of the call
- −15.2%
Revenue & Expenses Breakdown
Sumitomo Pharma Co Ltd
Earnings Waterfall
Sumitomo Pharma Co Ltd
The intrinsic value for Sumitomo Pharma Co Ltd (SMDPY) under the Base Case is hidden USD.
Compared with the current market price of 12.8 USD, the stock appears hidden.